Articoli di riviste: "Pathogenic"

1

Gvozdyak, R. I. "«Pathogen-1» Experiment Aggression of pathogenic bacteria in microgravity". Kosmìčna nauka ì tehnologìâ 6, n. 4 (30 luglio 2000): 111. http://dx.doi.org/10.15407/knit2000.04.119.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

2

Ruchel, Reinhard. "Proteinasen pathogener Pilze: Proteinases of pathogenic fungi". Mycoses 42, S1 (aprile 1999): 48–52. http://dx.doi.org/10.1111/j.1439-0507.1999.tb04527.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

3

Gharwalova, Lucia, Marketa Kulisova, Anastasiia Vasyliuk, Helena Maresova, Andrea Palyzova, Linda Nedbalova e Irena Kolouchova. "Sphingolipids of plant pathogenic fungi". Plant Protection Science 57, No. 2 (1 marzo 2021): 134–39. http://dx.doi.org/10.17221/131/2020-pps.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Abstract (sommario):

Glycosphingolipids in filamentous fungi are significant components of the plasma membrane and are vital for different cellular processes, such as growth, morphological transition or signal transduction. Fungal growth inhibitors targeting glycosylinositolphosphoceramide (GIPCs) biosynthesis or antifungal compounds binding to GIPCs present in membranes could present a safe way of preventing fungal growth on crops since GIPCs are not present in mammalian cells. Mass spectrometry-based shotgun lipidomics was used to analyze sphingolipids of 11 fungal strains isolated from plant material. Molecular species with inositol ceramides containing zero to five carbohydrates were identified. Differences in the amount of individual molecular species were influenced by the taxonomic affiliation. All tested strains exhibited a relatively high content (more than 40 mol.%) of GIPCs with three and more saccharides attached to the polar head. It could be assumed that the sphingolipid profiles of the tested plant pathogens would be an adaptation mechanism to antifungal plant defensins.

4

Finn, Albert F., e Peter D. Gorevic. "Pathogenic paraproteins". Current Opinion in Rheumatology 2, n. 4 (agosto 1990): 652–60. http://dx.doi.org/10.1097/00002281-199002040-00017.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

5

Horvat, Rebecca T. "PATHOGENIC FUNGI". Shock 30, n. 6 (dicembre 2008): 753. http://dx.doi.org/10.1097/01.shk.0000336210.36795.86.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

6

Gould, EA, e T. Solomon. "Pathogenic flaviviruses". Lancet 371, n. 9611 (febbraio 2008): 500–509. http://dx.doi.org/10.1016/s0140-6736(08)60238-x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

7

DIPERRI, G. "PATHOGENIC ENTAMOEBA". Lancet 331, n. 8595 (maggio 1988): 1166. http://dx.doi.org/10.1016/s0140-6736(88)91980-0.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

8

Gao, Shou-Jiang. "Pathogenic procedures". Trends in Microbiology 5, n. 3 (marzo 1997): 125–26. http://dx.doi.org/10.1016/s0966-842x(97)87506-3.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

9

Tran Van Nhieu, Guy. "Pathogenic paradox?" Trends in Microbiology 7, n. 3 (marzo 1999): 102. http://dx.doi.org/10.1016/s0966-842x(99)01473-0.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

10

Casci, Tanita. "Pathogenic conversions". Nature Reviews Genetics 13, n. 1 (16 dicembre 2011): 2. http://dx.doi.org/10.1038/nrg3143.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

11

Dempsey, Laurie A. "Pathogenic antibodies". Nature Immunology 20, n. 11 (22 ottobre 2019): 1414. http://dx.doi.org/10.1038/s41590-019-0535-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

12

POOLMAN, J. "Pathogenic neisseriae". Lancet 336, n. 8722 (ottobre 1990): 1061. http://dx.doi.org/10.1016/0140-6736(90)92518-m.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

13

Prasanna, Arun N., e Sarika Mehra. "Comparative Phylogenomics of Pathogenic and Non-Pathogenic Mycobacterium". PLoS ONE 8, n. 8 (28 agosto 2013): e71248. http://dx.doi.org/10.1371/journal.pone.0071248.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

14

Foley, J. F. "Detecting a Pathogenic Activity, Not a Pathogenic Molecule". Science Signaling 7, n. 343 (16 settembre 2014): ec252-ec252. http://dx.doi.org/10.1126/scisignal.2005897.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

15

Thongboonkerd, Visith, Wararat Chiangjong, Putita Saetun, Supachok Sinchaikul, Shui-Tein Chen e Uraiwan Kositanont. "Analysis of differential proteomes in pathogenic and non-pathogenic Leptospira : Potential pathogenic and virulence factors". PROTEOMICS 9, n. 13 (luglio 2009): 3522–34. http://dx.doi.org/10.1002/pmic.200700855.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

16

Bøe, Johs. "On the Distinction Between Pathogenic and Non-Pathogenic Staphylococci". Acta Pathologica Microbiologica Scandinavica 21, n. 5 (14 agosto 2009): 721–30. http://dx.doi.org/10.1111/j.1699-0463.1944.tb04972.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

17

Wurtzel, Omri, Nina Sesto, J. R. Mellin, Iris Karunker, Sarit Edelheit, Christophe Bécavin, Cristel Archambaud, Pascale Cossart e Rotem Sorek. "Comparative transcriptomics of pathogenic and non‐pathogenic Listeria species". Molecular Systems Biology 8, n. 1 (gennaio 2012): 583. http://dx.doi.org/10.1038/msb.2012.11.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

18

DiMiceli, Lauren. "Distinguishing Between Pathogenic and Non-Pathogenic Species of Entamoeba". Laboratory Medicine 35, n. 10 (1 ottobre 2004): 613–15. http://dx.doi.org/10.1309/b81npvaw8y4bgy11.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

19

Roberts, Glenn D. "Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes". Mayo Clinic Proceedings 63, n. 10 (ottobre 1988): 1061–62. http://dx.doi.org/10.1016/s0025-6196(12)64931-3.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

20

Prasad, Rajendra, Frédéric Devaux, Sanjiveeni Dhamgaye e Dibyendu Banerjee. "Response of pathogenic and non-pathogenic yeasts to steroids". Journal of Steroid Biochemistry and Molecular Biology 129, n. 1-2 (marzo 2012): 61–69. http://dx.doi.org/10.1016/j.jsbmb.2010.11.011.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

21

Hopsu-Havu, V. K., C. E. Sonck e Elvi Tunnela. "Production of Elastase by Pathogenic and Non-Pathogenic Fungi". Mycoses 15, n. 3 (24 aprile 2009): 105–10. http://dx.doi.org/10.1111/j.1439-0507.1972.tb01357.x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

22

Ahearn, Donald G. "Medical Mycology: The Pathogenic Fungi and the Pathogenic Actinomycetes". JAMA: The Journal of the American Medical Association 260, n. 12 (23 settembre 1988): 1794. http://dx.doi.org/10.1001/jama.1988.03410120140051.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

23

Gaminda, K. A. P. "DEOXYRIBOZYMES IN DETECTION OF PATHOGENIC BACTERIA". Biotechnologia Acta 14, n. 5 (ottobre 2021): 5–20. http://dx.doi.org/10.15407/biotech14.05.005.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Abstract (sommario):

Aim. The purpose of the review was to analyze the use of DNAzyme biosensors for the detection of pathogens. In the recent years, deoxyribozymes (DNAzymes) have a significant impact as biosensors in diverse fields, from detection of metal ions in the environment to theranostic applications and detection of microorganisms. Although routinely used sophisticated instrumental methods are available to detect pathogenic bacterial contamination, they involve time-consuming, complicated sample pre-treatment and expensive instruments. As an alternative, pathogen-specific DNAzymes have demonstrated a series of advantages: a non-destructive rapid analysis technique with in situ and real-time detection of bacteria with high sensitivity and selectivity. A wide range of pathogen-specific DNAzymes has been developed using colorimetric and fluorescence-based detections for pathogenic bacterial contamination in various samples. The current review summarizes the in vitro selection of pathogen-specific DNAzymes, various strategies utilized in the sensor designs, and their potential use in theranostic applications.

24

Orlyankin, B. G., e T. I. Aliper. "Porcine pathogenic viruses". "Veterinary Medicine" Journal 23, n. 01 (gennaio 2020): 03–08. http://dx.doi.org/10.30896/0042-4846.2020.23.1.03-08.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

25

Kaper, James B., James P. Nataro e Harry L. T. Mobley. "Pathogenic Escherichia coli". Nature Reviews Microbiology 2, n. 2 (febbraio 2004): 123–40. http://dx.doi.org/10.1038/nrmicro818.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

26

Parkhill, Julian, e Colin Berry. "Relative pathogenic values". Nature 423, n. 6935 (maggio 2003): 23–24. http://dx.doi.org/10.1038/423023a.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

27

Suerbaum, Sebastian, e Torkel Wadström. "Bacterial pathogenic factors". Current Opinion in Gastroenterology 11 (1995): 11–15. http://dx.doi.org/10.1097/00001574-199501001-00003.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

28

Figura, Natale, e Soad Tabaqchali. "Bacterial pathogenic factors". Current Opinion in Gastroenterology 12 (gennaio 1996): 11–15. http://dx.doi.org/10.1097/00001574-199601001-00003.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

29

Bisel, Ryan S., e Debra J. Ford. "Diagnosing Pathogenic Eschatology". Communication Studies 59, n. 4 (21 novembre 2008): 340–54. http://dx.doi.org/10.1080/10510970802467395.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

30

Charlotte, Harrison. "Identifying pathogenic pathways". Nature Reviews Drug Discovery 12, n. 7 (luglio 2013): 506. http://dx.doi.org/10.1038/nrd4061.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

31

Barešić, Anja, e Andrew C. R. Martin. "Compensated pathogenic deviations". BioMolecular Concepts 2, n. 4 (1 agosto 2011): 281–92. http://dx.doi.org/10.1515/bmc.2011.025.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Abstract (sommario):

AbstractDeleterious or ‘disease-associated’ mutations are mutations that lead to disease with high phenotype penetrance: they are inherited in a simple Mendelian manner, or, in the case of cancer, accumulate in somatic cells leading directly to disease. However, in some cases, the amino acid that is substituted resulting in disease is the wild-type native residue in the functionally equivalent protein in another species. Such examples are known as ‘compensated pathogenic deviations’ (CPDs) because, somewhere in the second species, there must be compensatory mutations that allow the protein to function normally despite having a residue which would cause disease in the first species. Depending on the nature of the mutations, compensation can occur in the same protein, or in a different protein with which it interacts. In principle, compensation can be achieved by a single mutation (most probably structurally close to the CPD), or by the cumulative effect of several mutations. Although it is clear that these effects occur in proteins, compensatory mutations are also important in RNA potentially having an impact on disease. As a much simpler molecule, RNA provides an interesting model for understanding mechanisms of compensatory effects, both by looking at naturally occurring RNA molecules and as a means of computational simulation. This review surveys the rather limited literature that has explored these effects. Understanding the nature of CPDs is important in understanding traversal along fitness landscape valleys in evolution. It could also have applications in treating diseases that result from such mutations.

32

Jauniaux, E. "I158 PATHOGENIC MECHANISMS". International Journal of Gynecology & Obstetrics 119 (ottobre 2012): S199—S200. http://dx.doi.org/10.1016/s0020-7292(12)60188-x.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

33

Angell, E. "Pathogenic waste treatment". Environment International 23, n. 3 (1997): IX—X. http://dx.doi.org/10.1016/s0160-4120(97)88023-3.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

34

Kaper, James B. "Pathogenic Escherichia coli". International Journal of Medical Microbiology 295, n. 6-7 (ottobre 2005): 355–56. http://dx.doi.org/10.1016/j.ijmm.2005.06.008.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

35

Fattakhov, R. "Genesis pathogenic ecosystems". Parasitology International 47 (agosto 1998): 329. http://dx.doi.org/10.1016/s1383-5769(98)80967-7.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

36

Bahcall, Orli G. "Classifying pathogenic variation". Nature Reviews Genetics 16, n. 3 (18 febbraio 2015): 131. http://dx.doi.org/10.1038/nrg3915.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

37

Holmes, Edward C. "Virology: Pathogenic passengers". Nature 478, n. 7369 (ottobre 2011): 319–20. http://dx.doi.org/10.1038/478319a.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

38

Shoenfeld, Yehuda. "Pathogenic natural autoantibodies". Clinical Immunology Newsletter 13, n. 2-3 (febbraio 1993): 13–19. http://dx.doi.org/10.1016/0197-1859(93)90020-k.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

39

Wackett, Lawrence P. "Plant pathogenic microorganisms". Environmental Microbiology 17, n. 10 (ottobre 2015): 4143–44. http://dx.doi.org/10.1111/1462-2920.13067.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

40

Kiberstis, P. A. "NEUROSCIENCE: Pathogenic Tangles". Science 287, n. 5462 (31 marzo 2000): 2377f—2377. http://dx.doi.org/10.1126/science.287.5462.2377f.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

41

Voelkner, Nadine. "Managing pathogenic circulation". Security Dialogue 42, n. 3 (giugno 2011): 239–59. http://dx.doi.org/10.1177/0967010611405393.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

42

Broder, Samuel. "Pathogenic Human Retroviruses". New England Journal of Medicine 318, n. 4 (28 gennaio 1988): 243–45. http://dx.doi.org/10.1056/nejm198801283180409.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

43

H., G. C., e J. A. von Arx. "Plant Pathogenic Fungi". Mycologia 79, n. 6 (novembre 1987): 919. http://dx.doi.org/10.2307/3807701.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

44

van West, Pieter, e Gordon W. Beakes. "Animal pathogenic Oomycetes". Fungal Biology 118, n. 7 (luglio 2014): 525–26. http://dx.doi.org/10.1016/j.funbio.2014.05.004.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

45

Harborne, Jeffrey B. "Plant pathogenic bacteria". Phytochemistry 27, n. 5 (gennaio 1988): 1569–70. http://dx.doi.org/10.1016/0031-9422(88)80251-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

46

Calam, John. "4 Pathogenic mechanisms". Baillière's Clinical Gastroenterology 9, n. 3 (settembre 1995): 487–506. http://dx.doi.org/10.1016/0950-3528(95)90044-6.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

47

Solbrig, Marylou V. "Human pathogenic arenaviruses". Annals of Neurology 64, n. 3 (25 febbraio 2008): 355–56. http://dx.doi.org/10.1002/ana.21350.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

48

Filip, Z., D. Kaddu-Mulindwa e G. Milde. "Survival of Some Pathogenic and Facultative Pathogenic Bacteria in Groundwater". Water Science and Technology 20, n. 3 (1 marzo 1988): 227–31. http://dx.doi.org/10.2166/wst.1988.0105.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Abstract (sommario):

In model experiments carried out in the laboratory the survival of bacteria in groundwater kept at 10±l °C was tested. Only two of the tested bacteria species did not survive longer than 10 - 30 days. Escherichia coli, Salmonella typhimurium, Pseudomonas aeruginosa and other pathogenic or facultative pathogenic bacteria survived up to 100 days or even more in ground-water with or without the addition of sand from an aquifer. These results can be of importance for determining groundwater protection zones.

49

Napalkova, G. M., I. I. Korsakova, N. P. Khrapova, N. N. Piven', L. V. Lomova e T. V. Bulatova. "Differentiation of Pathogenic and Non-Pathogenic Burkholderias Using Rocket Immunoelectrophoresis". Problems of Particularly Dangerous Infections, n. 4(106) (20 agosto 2010): 37–38. http://dx.doi.org/10.21055/0370-1069-2010-4(106)-37-38.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Abstract (sommario):

Demostrated is the possibility to differentiate virulent strains of melioidosis and glanders etiological agents from avirulent ones and closely related microorganisms according to the presence of the antigenic complex 8, using rocket immunoelectrophoresis with the serum containing antibodies to this complex.

50

Korva, Miša, Nataša Knap, Katarina Rus, Luka Fajs, Gašper Grubelnik, Matejka Bremec, Tea Knapič, Tomi Trilar e Tatjana Županc. "Phylogeographic Diversity of Pathogenic and Non-Pathogenic Hantaviruses in Slovenia". Viruses 5, n. 12 (10 dicembre 2013): 3071–87. http://dx.doi.org/10.3390/v5123071.

Testo completo

Gli stili APA, Harvard, Vancouver, ISO e altri

Articoli di riviste sul tema "Pathogenic"

Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili